Neurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?

Insider buying vs selling

Have Neurocrine Biosciences Inc insiders been buying or selling?
Ingrid DelaetChief Regulatory Officer2024-05-31273$136.55
Ingrid DelaetChief Regulatory Officer2024-05-31273$79.02
Stephen A. SherwinDirector2024-05-2925,000$42.76
Stephen A. SherwinDirector2024-05-2925,000$133.46
Stephen A. SherwinDirector2024-05-2915,000$47.89
Stephen A. SherwinDirector2024-05-2915,000$133.47
Leslie V. NorwalkDirector2024-05-171,106$141.82
Richard F. PopsDirector2024-05-172,100$141.84
Shalini SharpDirector2024-05-171,106$141.90
Matt AbernethyChief Financial Officer2024-05-1515,000$140.24

1 of 17

NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBIX insiders and whales buy or sell their stock.

NBIX Shareholders

What type of owners hold Neurocrine Biosciences Inc stock?
Bvf Partners L P34.84%35,058,600$4.72BInsider
Blackrock Inc13.67%13,760,970$1.85BInstitution
Vanguard Group Inc9.87%9,930,926$1.34BInstitution
State Street Corp3.96%3,989,961$537.13MInstitution
Jpmorgan Chase Co2.28%2,295,108$308.97MInstitution
Renaissance Technologies LLC2.24%2,251,646$303.12MInstitution
Morgan Stanley2.05%2,065,636$278.08MInstitution
Bellevue Group Ag2.04%2,055,874$276.76MInstitution
Price T Rowe Associates Inc1.81%1,820,796$245.12MInstitution
Geode Capital Management LLC1.70%1,713,714$230.70MInstitution

1 of 3

NBIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBIX69.89%30.11%Net SellingNet Selling
VTRS79.74%17.85%Net SellingNet Selling
CTLT77.51%22.49%Net BuyingNet Selling
ELAN90.47%9.53%Net SellingNet Selling

Neurocrine Biosciences Stock Ownership FAQ

Who owns Neurocrine Biosciences?

Neurocrine Biosciences (NASDAQ: NBIX) is owned by 92.33% institutional shareholders, 39.79% Neurocrine Biosciences insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Neurocrine Biosciences shareholder, owning 35.06M shares representing 34.84% of the company. Bvf Partners L P's Neurocrine Biosciences shares are currently valued at $4.78B.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.